Physician profile
Albert E Odom
NPI 1790737997
$25,629.77
in general payments reported to CMS, 2019-2025
12 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $1,829 · 2021: $13K · 2022: $1,171 · 2023: $1,416 · 2024: $6,447 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,875 · Travel and Lodging: $866 · Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,875.00 |
| Travel and Lodging | $865.64 |
| Food and Beverage | $273.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $23,935.88 | 2019-2024 | Acessa Provu System |
| Hologic Sales and Service, LLC | $939.80 | 2021-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Applied Medical Resources Corporation | $509.94 | 2022 | |
| Optumhealth Care Solutions, LLC | $66.98 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Exact Sciences Corporation | $37.80 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $27.96 | 2025 | Myfembree |
| Supernus Pharmaceuticals, INC. | $24.80 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $24.80 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $19.41 | 2022 | |
| Exeltis, USA INC. | $18.70 | 2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $16.39 | 2022 | |
| Organon LLC | $7.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Odom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.